Thibault Reverdy (Thibaut Reverdy)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Liver Metastases

Epidermal Growth Factor Receptor

Cross Sectional

Metastatic Breast Cancer

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ismail Essâdi, Zineb Benbrahim, Mohamed Kaakoua, Thibault Reverdy, Pauline Corbaux, Gilles Freyer
HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments. Cancers 15 (6) (2023)
Ismail Essâdi, Zineb Benbrahim, Mohamed Kaakoua, Thibault Reverdy, Pauline Corbaux, Gilles Freyer
HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments. Cancers 15 (6) (2023)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Madeleine Maugeais, Julien Péron, Stéphane Dalle, Amélie Boespflug, Michaël Duruissaux, Pauline Corbaux, Thibault Reverdy, Gulsum Sahin, Aurélie Rabier, Jonathan Lopez, Nathalie Freymond, Denis Maillet
Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study. Biomedicines 11 (1) (2022)
Julien Péron, Thibault Reverdy, Colette Smentek, Marion Cortet, Benoît You, Gilles Freyer
Methods and Designs of Modern Breast Cancer Confirmatory Trials. Cancers 13 (11) (2021)
Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, Pauline Corbaux, Amélie Boespflug, Michaël Duruisseaux, Lize Kiakouama-Maleka, Thibault Reverdy, Madeleine Maugeais, Gulsum Sahin, Denis Maillet, Julien Péron
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes. Cancers 13 (10) (2021)
Romain Varnier, Christophe Sajous, Solène de Talhouet, Colette Smentek, Julien Péron, Benoît You, Thibault Reverdy, Gilles Freyer
Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives. Cancers 13 (19) (2021)
Thibault Reverdy, Christophe Sajous, Julien Péron, Olivier Glehen, Naoual Bakrin, Witold Gertych, Jonathan Lopez, Benoit You, Gilles Freyer
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and Perspectives. Cancers 12 (9) (2020)